Walgreens Sees "Optionality," Or Flexible Participation, As The Way Forward With Hybrid Trials
Source: Clinical Leader
Walgreens Head of Decentralized Clinical Trials John Campbell believes clinical trials will one day allow patient to choose when and where they will participate in a clinical trial. Campbell contends true patient centricity would allow patients to pick whether they’re seen at home, at a site, at a pharmacy, or any combination of locations.
access the Video!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.
Subscribe to Clinical Leader
X
Subscribe to Clinical Leader
This website uses cookies to ensure you get the best experience on our website. Learn more